LeonaBio, Inc. (LONA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$45.73M | +52.9% |
| 2024 | -$97.17M | +3.6% |
| 2023 | -$100.75M | -39.0% |
| 2022 | -$72.47M | -68.1% |
| 2021 | -$43.10M | -78.7% |
| 2020 | -$24.11M | -549.4% |
| 2019 | -$3.71M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$45.73M | +52.9% |
| 2024 | -$97.17M | +3.6% |
| 2023 | -$100.75M | -39.0% |
| 2022 | -$72.47M | -68.1% |
| 2021 | -$43.10M | -78.7% |
| 2020 | -$24.11M | -549.4% |
| 2019 | -$3.71M | — |